APA (7th ed.) Citation

Chamuleau, M. E., Wang, S., Nijland, M., Strobbe, L., Oosterveld, M., Boersma, R., . . . Alizadeh, A. A. (2025). 41 | PROSPECTIVE VALIDATION OF END OF TREATMENT ctDNA‐MRD BY PhasED‐Seq IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL. Hematological oncology, 43, 1. https://doi.org/10.1002/hon.70093_41

Chicago Style (17th ed.) Citation

Chamuleau, M. E., et al. "41 | PROSPECTIVE VALIDATION OF END OF TREATMENT CtDNA‐MRD BY PhasED‐Seq IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL." Hematological Oncology 43 (2025): 1. https://doi.org/10.1002/hon.70093_41.

MLA (9th ed.) Citation

Chamuleau, M. E., et al. "41 | PROSPECTIVE VALIDATION OF END OF TREATMENT CtDNA‐MRD BY PhasED‐Seq IN DLBCL PATIENTS FROM A NATIONAL HOVON TRIAL." Hematological Oncology, vol. 43, 2025, p. 1, https://doi.org/10.1002/hon.70093_41.